XBiotech Inc.XBITNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank15
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-39.92M
↓ 86% vs avg
Percentile
P15
Within normal range
Streak
4 yr
Consecutive declineContracting
Average
$-21.46M
Historical baseline
PeriodValueYoY Change
2025$-39.92M-28.9%
2024$-30.96M-65.4%
2023$-18.73M-26.3%
2022$-14.82M-121.3%
2021$69.44M+206.6%
2020$-65.15M-256.6%
2019$-18.27M-10.5%
2018$-16.54M+50.9%
2017$-33.65M+26.9%
2016$-46.02M-